STOK

NASDAQStock

Stoke Therapeutics, Inc.

$36.77-1.16 (-3.06%)

52-Week Range

$5.90

$38.35

Key Stats

Market Cap

2.1B

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.19

Volume

347.2K

Avg Volume

814.2K

Performance

+13.22%

+10.61%

+55.90%

YTD

+18.06%

+349.82%

+271.11%

-29.89%

Price Chart

ETF Exposure

STOK is held by 79 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
HDG	ProShares - Hedge Replication ETF	0.01%	50	$2K	$23.2M	0.95%
SPGM	State Street SPDR Portfolio MSCI Global Stock Market ETF	0.01%	2,932	$109K	$1.43B	0.09%
DCOR	Dimensional - US Core Equity 1 ETF	0.01%	4,395	$169K	$2.68B	0.14%
ONEQ	FIDELITY NASDAQ COMPOSITE INDEX ETF	0.01%	16,035	$615K	$9.01B	0.21%
DFAU	Dimensional - US Core Equity Market ETF	0.00%	10,213	$392K	$10.55B	0.12%
ITOT	iShares Core S&P Total U.S. Stock Market ETF	0.00%	65,836	$2.5M	$81.53B	0.03%
IWV	iShares Russell 3000 ETF	0.00%	13,431	$515K	$17.58B	0.20%
SCHB	Schwab U.S. Broad Market ETF	0.00%	28,492	$1.1M	$38.14B	0.03%
AVSC	Avantis U.S. Small Cap Equity ETF	0.00%	1,254	$48K	$2.37B	0.25%
DFUS	Dimensional - US Equity Market ETF	0.00%	10,858	$416K	$18.80B	0.09%
VTHR	Vanguard Russell 3000 ETF	0.00%	3,738	$113K	$5.50B	0.06%
VTI	Vanguard Total Stock Market ETF	0.00%	1,696,780	$51.5M	$2.10T	0.03%
ITDE	iShares LifePath Target Date 2045 ETF	0.00%	24	$936	$64.1M	0.11%
ITDF	iShares LifePath Target Date 2050 ETF	0.00%	29	$1K	$59.0M	0.11%
ITDG	iShares LifePath Target Date 2055 ETF	0.00%	24	$923	$42.9M	0.12%
ITDH	iShares LifePath Target Date 2060 ETF	0.00%	16	$609	$28.3M	0.12%
ITDI	iShares LifePath Target Date 2065 ETF	0.00%	12	$461	$21.4M	0.12%
ITDJ	iShares LifePath Target Date 2070 ETF	0.00%	5	$204	$9.5M	0.12%
AVUS	Avantis U.S. Equity ETF	0.00%	679	$26K	$11.08B	0.15%
DFSU	Dimensional - US Sustainability Core 1 ETF	0.00%	33	$1K	$1.91B	0.15%
DFUV	Dimensional - US Marketwide Value ETF	0.00%	341	$13K	$13.50B	0.21%
ITDB	iShares LifePath Target Date 2030 ETF	0.00%	4	$144	$61.4M	0.09%
ITDC	iShares LifePath Target Date 2035 ETF	0.00%	12	$478	$81.5M	0.10%
ITDD	iShares LifePath Target Date 2040 ETF	0.00%	21	$814	$81.7M	0.11%
LSLT	Pacer Salt Low truBeta US Market ETF	0.00%	1,200	$34K	$6.8M	0.60%
SLT	Pacer Salt High truBeta US Market ETF	0.00%	1,200	$34K	$6.3M	0.60%
TRPL	Pacer Metaurus US Large Cap Dividend Multiplier 300 ETF	0.00%	1,200	$34K	$1.0M	0.79%
VETS	Pacer Military Times Best Employers ETF	0.00%	1,200	$34K	$1.9M	0.60%
VIRS	Pacer BioThreat Strategy ETF	0.00%	1,200	$34K	$3.7M	0.70%

PreviousPage 2 of 2

About STOK ETF Exposure

Stoke Therapeutics, Inc. (STOK) is held by 79 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 2.1B, STOK is a widely held institutional stock. The stock currently trades at $36.77. Investors can gain exposure to STOK through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold STOK, sorted by portfolio weight.